A novel antigenic protein of pathogenic Leptospira, Loa22, was identified by using the PhoA fusion method followed by immunoblotting with convalescent mouse sera. Loa22 was shown to be a lipoprotein having a C-terminal OmpA consensus domain. Loa22 was detected among pathogenic leptospires but not among non-pathogenic leptospires, suggesting the possible involvement of this protein in virulence. The results of three different experiments suggested that Loa22 is located in the outer membrane and a small portion is exposed on the cell surface. Thus, Loa22 may be a candidate for a novel vaccine against infection with pathogenic leptospires.
Introduction
Leptospira is the causative agent of leptospirosis, an important zoonotic disease throughout the world. There are more than 230 serovars among the pathogenic leptospires [1] . The variation in the carbohydrate moiety of lipopolysaccharide (LPS) accounts for the antigenic diversity of pathogenic leptospires. It has been well demonstrated that leptospiral LPS is a serovar-speci¢c protective immunogen [1] . In contrast to LPS, proteins extracted from a pathogenic Leptospira can confer protective immunity against the challenge with a heterologous serovar strain of Leptospira in an experimental animal model [2] . This result suggests that leptospiral protein(s) can be candidates for a new vaccine that prevents infection with a broad spectrum of Leptospira. Some outer membrane proteins of Leptospira, lipoproteins LipL32 (also known as Hap1), LipL41 and the porin OmpL1, have been found to be protective immunogens that are conserved among various pathogenic leptospires [3^7] .
In this study, we identi¢ed a novel lipoprotein with a C-terminal OmpA domain, Loa22, which reacts with convalescent mouse sera and is highly conserved among pathogenic leptospires.
Materials and methods

Leptospira strains and culture conditions
Leptospira interrogans serovar manilae strain UP-MMC and Leptospira reference strains were cultivated in liquid modi¢ed Korthof medium with 10% rabbit serum at 30 ‡C [1, 8] .
Construction of PhoA fusion library
Genomic DNA was prepared from L. interrogans UP-MMC using a cetyltrimetylammonium bromide precipitation method [9] . The DNA was partially digested with Sau3AI, puri¢ed through sucrose gradient centrifugation, and fragments ranging from 0.5 to 4 kb were isolated and ligated to BamHI-digested pJDT1, pJDT2 and pJDT3. These vectors contain a phoA gene lacking a signal peptide in a di¡erent reading frame with respect to the BamHI site [10] . Escherichia coli JM109 was used as the host strain to make a PhoA fusion library. The transformants were plated on LB agar containing 100 Wg ml 31 of ampicillin and 40 Wg ml 31 of 5-bromo-4-chloro-3-indolyl phosphate (XP ; Sigma). DNA sequencing was performed by the dideoxynucleotide chain termination method using the BigDye Terminator Cycle Sequencing Ready Reaction kit ver. 2.0 (Applied Biosystems).
Convalescent mouse sera and immunoblotting experiments
Nine-week-old C3H/HeJ mice were inoculated intraperitoneally with 1U10
7 UP-MMC. The mice were killed on the 28th day after challenge, and their sera were harvested for immunoblotting experiments [8] . All animal experiments were approved by the animal research committee of the National Institute of Infectious Diseases.
Protein samples were subjected to sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) [11] and Western blotting [12] . The blotted membrane was incubated in 900-fold diluted convalescent mouse sera or in 1000-fold diluted rabbit anti-E. coli PhoA serum followed by incubation in horseradish peroxidase-conjugated secondary antibody. Positive signals were detected using the ECL Western blotting detection system (Amersham Biosciences). According to the PhoA activity and the reactivity with both anti-PhoA serum and convalescent mouse sera, one clone (PA-2) was selected for further characterization.
IPCR
The 3P-terminal end of the loa22 gene was ampli¢ed by the method of IPCR [13] . PCR was conducted with Taq DNA polymerase (Ex-Taq, TaKaRa) using ClaI-digested/ self-ligated genomic DNA of L. interrogans UP-MMC as the template, and the sense primer (5P-GGTGATTT-CAGCGAGTGGTC-3P) and the antisense primer (5P-GGGGTTTGGTATCAGAGTGT-3P).
Expression and puri¢cation of recombinant GST/Loa22 fusion proteins
The loa22 gene was ampli¢ed with the GeneAmp High Fidelity PCR System (Applied Biosystems) using the upstream primer Loa22F/GST (5P-GCGCGGATCCAT-GGTCAAGAAGATCCTGAATCTG-3P) and the downstream primer Loa22R/GST (5P-GCCGCTCGAGTT-GTTGTGGTGCGGAAGTCG-3P). These primers contain a BamHI site and a XhoI site, respectively, near their 5P ends (underlined). L. interrogans UP-MMC genomic DNA was used as the template. The PCR products were puri¢ed with a High Pure PCR product puri¢cation kit (Roche), digested with BamHI and XhoI, and cloned into the GST vector pGEX-6P-1 (Amersham Biosciences). To express the GST fusion protein, E. coli JM109 was transformed with the plasmid harboring a gene for GST/ Loa22 fusion protein. The GST fusion protein expressed in E. coli was puri¢ed using glutathione Sepharose 4B (Amersham Biosciences) according to the supplier's instruction.
Production of anti-Loa22 serum
The Loa22 protein was cleaved from the GST/Loa22 fusion protein with PreScission protease (Amersham Biosciences), and puri¢ed according to the supplier's instruction. Antiserum against Loa22 was raised in mice by injecting 10 Wg of puri¢ed Loa22 with complete Freund's adjuvant and booster injections of the same amount of protein without the adjuvant 2 and 4 weeks later.
Labeling of Loa22 protein with [
3 H]palmitate
Palmitate radiolabeling was performed as described by Akins et al. [14] , except that 1% casamino acids were included in the medium during the cultivation.
Triton X-114 extraction of L. interrogans
L. interrogans UP-MMC cells were extracted with Triton X-114 (TX114) as described by Zuerner et al. [15] , except that 0.5% protease inhibitor cocktail (Sigma) was added during the extraction procedure.
Surface immunoprecipitation
About 2U10
9 L. interrogans UP-MMC cells were pelleted at 4000Ug for 15 min and resuspended in 1 ml of Tris-bu¡ered saline containing 2% bovine serum albumin. The suspension was mixed with 5 Wl of heat-inactivated (30 min at 56 ‡C) anti-Loa22 serum, and then gently shaken for 1 h at room temperature. The leptospires were pelleted at 4000Ug for 15 min, resuspended in 1 ml of phosphate-bu¡ered saline (PBS) containing 5 mM MgCl 2 , pelleted again at 4000Ug for 15 min, and then resuspended in 450 Wl of Tris^HCl (pH 8.0)^2 mM EDTA0 .5% protease inhibitor cocktail (Sigma). To this suspension, 50 Wl of 10% Triton X-100 (TX100) was added, and then the mixture was agitated for 30 min at 4 ‡C. The insoluble material was removed by centrifugation at 16 000Ug for 20 min. To the supernatant, 50 Wl of 2% deoxycholate, 2.5 Wl of 20% SDS, and 40 Wl of a slurry of Dynabeads protein A (Dynal) were added. This mixture was gently agitated for 1 h at 4 ‡C. The Dynabeads protein A^antibody^antigen complexes were washed three times in 10 mM Tris^HCl (pH 8.0) containing 0.01% TX100, and resuspended in SDS^PAGE sample bu¡er. Samples were subjected to SDS^PAGE and immunoblotting with antiLoa22 serum. A control experiment was performed in parallel under the same conditions as described above except that the anti-Loa22 serum was added after solubilization of leptospiral cells with TX100.
Proteinase K digestion
Proteinase K (PK) digestion was performed as described previously [16, 17] . About 5U10 8 L. interrogans UP-MMC cells were pelleted at 4000Ug for 15 min, resuspended in 1 ml of PBS containing 5 mM MgCl 2 , pelleted again at 4000Ug for 15 min, and then resuspended in 50 Wl of PBS containing 1 mM CaCl 2 and 5 mM MgCl 2 . The suspensions were treated with PK (0.4 mg ml 31 ), 0.01% TX100, PK plus 0.01% TX100, or PBS (as a control), and incubated for 30 min at 37 ‡C followed by the addition of phenylmethylsulfonyl £uoride to 1 mg ml 31 . Lysates of untreated, PK-treated, TX100-treated, and PK/TX100-treated leptospires were analyzed by immunoblotting as described above.
Results and discussion
Identi¢cation of Loa22
In recent years, the identi¢cation of immunogenic outer membrane proteins of pathogenic Leptospira has become a major focus of Leptospira research. The expression of proteins as PhoA fusions is a commonly employed genetic strategy for dissecting membrane topology in various prokaryotes including the spirochetes Borrelia and Treponema [14, 18] . In this study, we employed this method together with immunoblotting to identify leptospiral outer membrane proteins that react with convalescent mouse sera.
A genomic library of L. interrogans was constructed in pJDT1, 2 and 3 plasmid vectors. Among 51 PhoA+ transformants on XP medium, one clone (PA-2) reacted strongly with convalescent mouse sera on Western blotting (data not shown). Sequence analysis of the DNA insert in clone PA-2 (a derivative of pJDT3; pLOAN) revealed the presence of putative 335 and 310 promoter regions and a ribosomal binding site immediately upstream of a part (123 amino acids) of an open reading frame (ORF) fused in-frame to PhoA (data not shown). The entire ORF was designated Loa22 (22-kDa Leptospira lipoprotein with OmpA domain). The hydrophobicity plot and the amino acid sequence (F-T-L-C) in the N-terminus of the predicted Loa22 protein suggested that this protein might be a lipoprotein. In order to con¢rm that Loa22 is a lipoprotein, E. coli harboring the plasmid pLOAN encoding Loa22/PhoA fusion was radiolabeled in vivo with [ 3 H]palmitate. As shown in Fig. 1 , the E. coli strain expressed a lipid-modi¢ed polypeptide with a molecular mass of 60 kDa on SDS^PAGE (lane 2) which co-migrated with the polypeptide recognized by both antiPhoA serum (lane 3) and convalescent mouse sera (data not shown).
Sequence comparison of Loa22 with other proteins
Next, we performed IPCR to obtain the full-length loa22 gene. The ampli¢ed DNA fragment contained DNA sequences identical to the insert of the plasmid pLOAN. The entire ORF of the loa22 gene encoded a polypeptide of 195 amino acids with a calculated molecular mass of 20 912 Da (accession number AB096686). Analysis of the Loa22 protein sequence using the NCBI database and BLAST revealed that Loa22 contains an OmpA consensus domain conserved in the C-terminus (pfam00691; identity, 36.5% (35/96) ; similarity, 57.3% (55/96) ; Fig. 2) , while the N-terminus of Loa22 does not show signi¢cant similarity with any other proteins. This is the ¢rst description of a protein with an OmpA domain in Leptospira. Recently, the whole genome sequence of L. interrogans serovar lai was reported (http://www. chgc.sh.cn/gn/), which shows that there are ¢ve kinds of proteins with an OmpA domain in its genome. The carboxy-terminal OmpA consensus domain contains a peptidoglycan-associating motif [19] , which is highly conserved in Loa22 (underline in Fig. 2) . One of the functions of OmpA is to provide physical linkage between the outer membrane and the underlying peptidoglycan layer, which plays a critical role in the structural integrity of the bac- Fig. 1 . Lipid modi¢cation of the Loa22/PhoA fusion expressed in E. coli and Western blotting with anti-PhoA serum. E. coli JM109 harboring plasmid pLOAN or pJDT3 was metabolically radiolabeled with [ 3 H]palmitate, and then the bacterial lysates were analyzed by SDSP AGE and £uorography (lanes 1 and 2) . The same protein samples prepared from E. coli JM109 harboring plasmid pLOAN or pJDT3 were subjected to SDS^PAGE and Western blotting with anti-PhoA serum (lane 3). Lanes: 1, E. coli harboring pJDT3 (vector only); 2 and 3, E. coli harboring the plasmid pLOAN. terial cell surface [19] . It is suggested that Loa22 may play a physiological role in the maintenance of the integrity of the membrane structure.
Expression of Loa22 in Leptospira species
The presence of Loa22 protein among a total of 17 pathogenic and non-pathogenic Leptospira strains was examined by immunoblot analysis with anti-Loa22 serum. As shown in Fig. 3 , a positive signal reacting with antiLoa22 serum could be detected at a position similar to that of Loa22 in all pathogenic strains, while no detectable level of the protein was observed in the non-pathogenic strains such as L. bi£exa and L. meyeri. Thus, a strong correlation was observed between pathogenicity and the presence of Loa22, suggesting the involvement of this protein in Leptospira virulence.
Cellular localization of Loa22
Based on the ¢nding that lipoproteins in the outer membrane are partitioned selectively into the TX114 hydrophobic detergent phase [20] , the localization of Loa22 was determined by the TX114 extraction method. Leptospiral cells were solubilized with 2% TX114 and the TX114-soluble fraction was further partitioned into two fractions, the aqueous phase and the detergent phase. Each fraction was analyzed by immunoblotting with anti-Loa22 serum. As shown in Fig. 4A , Loa22 existed in the detergent phase fraction but not the aqueous phase fraction (lanes A and D) , suggesting the localization of Loa22 in the leptospiral outer membrane. Loa22 in the TX114-soluble fraction before partitioning (Fig. 4A , lane S) was almost intact, but most of the Loa22 in the detergent phase fraction after partitioning was degraded (Fig.  4A, lane D) . We tried to prevent degradation by adding protease inhibitors (0.5% protease inhibitor cocktail ; Sigma) but failed. This might be due to the existence of leptospiral protease(s) in the detergent phase.
We examined whether Loa22 was located on the cell surface by surface immunoprecipitation and PK digestion. Leptospiral cells labeled with anti-Loa22 serum were solubilized with TX100 and precipitated with protein A-conjugated Dynabeads. The amount of surface-exposed Loa22 was compared with the total amount of Loa22 immunoprecipitated (Fig. 4B, lanes 2 and 3) . Only a small amount of the total Loa22 was found in the surface-labeled fraction (Fig. 4B, lane 3) , suggesting that a limited amount of Loa22 is exposed on the cell surface. However, the possibility still remained that the antibodies in our antiserum were not directed against surface-exposed epitopes of Loa22. Then, we employed PK digestion to further examine the surface localization of Loa22. PK treatment of the intact cells did not a¡ect Loa22 quantity (Fig.  4C, lanes 1 and 2) , while PK treatment after solubilization of cells completely eliminated Loa22 (Fig. 4C, lane 4) . This result suggested that the majority of Loa22 is located under the cell surface. As only a small portion of Loa22 is surface-exposed, the change in the amount of Loa22 after PK digestion might not be detected by Western blotting. Taken together, it was suggested that Loa22 is located in the outer membrane and only a small portion is exposed on the cell surface. In Borrelia burgdorferi, outer membrane lipoproteins, OspE/F/Elp paralogs, OspA and OspC, are located both on the outer membrane surface and in the periplasmic space [21, 22] . It has also been shown that these proteins are surface-exposed only in a subpopulation of B. burgdorferi [22] . Loa22 may behave like these proteins in Leptospira, but little is known about the mechanism of cellular localization of lipoproteins in spirochetes. Although OspA and OspC are partially exposed on the cell surface, these proteins are known to induce a protective e¡ect against borrelial infection [23, 24] . Thus, the Loa22 protein may also be a novel vaccine candidate for protection against Leptospira infection. Further studies will be required to con¢rm the signi¢cance of Loa22 for the virulence and protective activity.
